Trial of Activated Marrow Infiltrating Lymphocytes Alone or in Conjunction With an Allogeneic Granulocyte Macrophage Colony-stimulating Factor (GM-CSF)-Based Myeloma Cellular Vaccine in the Autologous Transplant Setting in Multiple Myeloma
PHASE2
Patient Population: Patients with active myeloma (Stage II/III) that have c...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Adoptive Immunotherapy With Activated Marrow Infiltrating Lymphocytes and Cyclophosphamide Graft-Versus-Host Disease Prophylaxis in Patients With Relapse of Hematologic Malignancies After Allogeneic Hematopoietic Cell Transplantation
PHASE1
This Phase 1 clinical study is designed to examine the safety and feasibili...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins